MaxQ Medical Secures $31.5 Million for Prostate Care

<p><strong><span class&equals;"legendSpanClass">SUNNYVALE <&sol;span><&sol;strong>&&num;8212&semi; <a href&equals;"https&colon;&sol;&sol;edge&period;prnewswire&period;com&sol;c&sol;link&sol;&quest;t&equals;0&amp&semi;l&equals;en&amp&semi;o&equals;4754887-1&amp&semi;h&equals;61940868&amp&semi;u&equals;https&percnt;3A&percnt;2F&percnt;2Fwww&period;maxqmedical&period;com&percnt;2F&amp&semi;a&equals;MaxQ&plus;Medical&percnt;2C&plus;Inc" target&equals;"&lowbar;blank" rel&equals;"nofollow noopener">MaxQ Medical&comma; Inc<&sol;a>&period;&comma; a private health-tech company developing an all-in-one transurethral imaging and therapy system for prostate care&comma; has closed a &dollar;31&period;5 million Series A financing&period; The round was led by Atlantic Blue Ventures&comma; S3 Ventures&comma; and Olympus Innovation Ventures with strong participation from our existing investor&comma; Hillside Capital&period; Funds will be used to grow the team and advance the company&&num;8217&semi;s clinical program&period;<&sol;p>&NewLine;<p>&&num;8220&semi;Men with prostate disease have had to choose between treatments that don&&num;8217&semi;t do enough and treatments that come with consequential tradeoffs and side-effects&period; The MaxQ system is designed to offer the durability of gold standard resective therapies with side-effects more comparable to tMIS solutions&comma;&&num;8221&semi; said Amir Tehrani&comma; CEO of MaxQ Medical&period;  &&num;8220&semi;I want to thank our investors for their support&comma; our exceptional team for their dedication&comma; and Amir Abolfathi&comma; our executive chairman&comma; co-leading this financing effort with me&period; This funding lets us continue the clinical evaluations already underway and move closer to giving physicians and their patients a better option&period;&&num;8221&semi;<&sol;p>&NewLine;<p>MaxQ Medical is developing a platform technology that combines advanced imaging with tissue-selective therapy in a single transurethral procedure&comma; giving urologists full visibility inside the prostate and the ability to treat what they see&comma; without the anatomic limitations of approaches that work from outside of the prostate&period; The design is intended to preserve the urethra and minimize side effects such as injury&comma; swelling and bleeding&comma; and impact on sexual functions which remain common concerns with current treatment options&period; The company&&num;8217&semi;s first indication is benign prostate hyperplasia &lpar;BPH&rpar;&comma; with plans to expand into focal therapy for prostate cancer and&comma; longer term&comma; into broader prostate diagnostics including biopsy and tumor mapping&period;<&sol;p>&NewLine;<p>&&num;8220&semi;Our work in semiconductor ultrasound has spanned decades&comma; and this is the first time we&&num;8217&semi;ve taken that foundation and built a complete imaging and therapy system around it&comma;&&num;8221&semi; said Professor Pierre Khuri-Yakub&comma; co-founder and Chief Scientific Officer of Orchard Ultrasound Innovation and Professor Emeritus of Electrical Engineering at Stanford University&period; &&num;8220&semi;MaxQ is our first spinout company&comma; and I&&num;8217&semi;m proud of how far the team has taken this technology&comma; from an idea in the lab to a platform that&&num;8217&semi;s ready to change how we care for men with prostate disease&period; I look forward to seeing it reach the patients who need it most&period;&&num;8221&semi;<&sol;p>&NewLine;<p>&&num;8220&semi;There&&num;8217&semi;s a strong need in urology for technology that allows physicians to see and treat the prostate in one setting&comma; and we&&num;8217&semi;re encouraged by MaxQ&&num;8217&semi;s vision for treating prostate disease&comma;&&num;8221&semi; said Gabriela Kaynor&comma; Chair of Olympus Innovation Ventures&period; &&num;8220&semi;We&&num;8217&semi;re excited to see the field develop novel technologies that can help shape and revolutionize the future of endoscopy-enabled care&period;&&num;8221&semi;<&sol;p>&NewLine;